Lansdowne Partners (UK)’s Summit Therapeutics SMMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,667,350	Closed	-$7.92M	–	56
2020 Q2	$7.92M	Sell	2,667,350 -1,561,350	-37%	-$5.38M	0.34%	31
2020 Q1	$10M	Buy	4,228,700 +2,632,034	+165%	+$4.52M	0.59%	20
2019 Q4	$2.56M	Hold	1,596,666	–	–	0.09%	24
2019 Q3	$2.86M	Hold	1,596,666	–	–	0.09%	29
2019 Q2	$2.02M	Hold	1,596,666	–	–	0.06%	27
2019 Q1	$2.92M	Hold	1,596,666	–	–	0.07%	32
2018 Q4	$1.84M	Hold	1,596,666	–	–	0.03%	34
2018 Q3	$3.54M	Hold	1,596,666	–	–	0.04%	34
2018 Q2	$3.91M	Hold	1,596,666	–	–	0.04%	39
2018 Q1	$20.6M	Hold	1,596,666	–	–	0.22%	18
2017 Q4	$17.7M	Hold	1,596,666	–	–	0.17%	23
2017 Q3	$20M	Buy	1,596,666 +666,666	+72%	+$8.64M	0.21%	18
2017 Q2	$10.6M	Hold	930,000	–	–	0.09%	24
2017 Q1	$12.3M	Hold	930,000	–	–	0.11%	22
2016 Q4	$7.96M	Hold	930,000	–	–	0.07%	21
2016 Q3	$8.43M	Hold	930,000	–	–	0.07%	20
2016 Q2	$7.52M	Hold	930,000	–	–	0.07%	22
2016 Q1	$6.34M	Hold	930,000	–	–	0.05%	23
2015 Q4	$10.7M	Hold	930,000	–	–	0.07%	23
2015 Q3	$9.68M	Hold	930,000	–	–	0.08%	22
2015 Q2	$9.82M	Hold	930,000	–	–	0.08%	23
2015 Q1	$11.5M	Buy	+930,000	New	+$10.5M	0.1%	21